| Description |
Epidermal Growth Factor (EGF), was originally discovered in crude preparations of nerve growth factor prepared from mouse submaxillary glands as an activity that induced early eyelid opening, incisor eruption, hair growth inhibition, and stunting of growth when injected into newborn mice. EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor). Recombinant, mouse Epidermal Growth Factor (rmEGF), produced in, E. coli, is a single non-glycosylated polypeptide chain containing 54 amino acids. A fully biologically active molecule, rmEGF is obtained by proprietary chromatographic techniques at GenScript with a molecular mass of 6.2kDa analyzed by reducing SDS-PAGE. |
| Storage |
Lyophilized recombinant, mouse Epidermal Growth Factor (rmEGF), remains stable up to 6 months at -80C from date of receipt. Upon reconstitution, rmEGF should be stable up to 2 weeks at 4C or up to 3 months at -20C. |
